SGMO Sangamo Therapeutics Inc.

$25.35 +14.19%

13,412,188 Shares Traded
1,743,164 Average Volume (last 30 days)

as of February 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $25.49 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-26.5%
If Intiated One Month Ago, Shorts Have Realized a Return of:-14.43%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.55%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingShort Squeeze Either Occurring or Squeeze Potential Rising - Pay More Attention to Catalysts and Fundamentals
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 9.79%
Short Interest8.09 million
Float82.64 million
Short Ratio5.45
Market Cap$1.88 billion
Market Maker ActivityDaily Short Volume


Sangamo bulls running after Gilead deal; shares up 13.4% (SeekingAlpha)
Midday Gainers / Losers (2/22/2018) (SeekingAlpha)
Sangamo Therapeutics: Great Start To 2018 - $3 Billion KITE Announcement (SeekingAlpha)
Premarket Gainers as of 9:05 am (02/22/2018) (SeekingAlpha)
Sangamo Therapeutics Q4 revenues up 47%; shares ahead 7% premarket (SeekingAlpha)
Sangamo up 6% premarket on Gilead deal to develop oncology-focused cell therapies (SeekingAlpha)
Sangamo Therapeutics beats by $0.03, beats on revenue (SeekingAlpha)
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer (PR Newswire)
Kite, a Gilead Company, and Sangamo Therapeutics Announce Collaboration to Develop Next-Generation Engineered Cell Therapies for the Treatment of Cancer (Business Wire)
Sangamo Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results (PR Newswire)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 62.2%

Earnings Stats

PE Ratio -36.81
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $13.01
50 Day Moving Average $18.66
52 Week High $23.9
52 Week Low $3.65

Data provided for free by IEX. Questions? Read the FAQ